Research Technician, In Vivo Biology

Oslo
Research & Development /
Fulltime /
On-site
Summary
We are seeking a Research Technician to join our In Vivo Biology team. In this hands-on role, you'll play a vital role in supporting our groundbreaking research efforts, contributing to the advancement of targeted radioligand therapies.

Are you a recent Master's-degree graduate who is detail-oriented and motivated individual with a keen interest in science? Do you thrive in a fast-paced environment and enjoy learning new techniques? If so, we encourage you to apply!

Responsibilities

    • Perform in vivo experimental procedures including implantation, dosing, sample collection and processing
    • Cultivation of mammalian cells
    • Collaborate with the research team to design and implement experiments
    • Conduct laboratory experiments, following established protocols and ensuring accuracy and precision
    • Collect, record, and organize experimental documents and data in electronic lab notebooks
    • Data analysis using relevant software and statistical tools
    • Contribute to writing research animal use ethical applications, study reports and SOPs
    • Perform literature searches to support technical development of research
    • Participate in daily tasks and duties for organization of the laboratory
    • Maintenance and calibrations of laboratory equipment
    • Maintenance of laboratory inventory

Qualifications & Education

    • Master’s degree in biomedical sciences or other relevant area of research
    • Experience in in vivo and in vitro laboratory research
    • Experience working with research animals (mice) with FELASA-C/CAREiN certificate or equivalent
    • Experience with working with open radioactive sources (added advantage)
    • Excellent written and verbal communication skills
    • Excellent organizational and problem-solving skills
About Us
ARTBIO is a clinical-stage radiopharmaceutical company redefining cancer care by creating a new class of alpha radioligand therapies (ARTs). The unique ARTBIO approach selects the optimal alpha-precursor isotope (212Pb) and tumor-specific targets to create therapeutics with the potential for highest efficacy and safety. The company's AlphaDirect™ technology, a first-of-its-kind 212Pb isolation method, enables a distributed manufacturing approach for the reliable production and delivery of ARTs. ARTBIO is advancing multiple pipeline programs with lead program AB001 currently in first in human trials. ARTBIO is shaped by a long-standing scientific legacy with nearly a century of pioneering work in radiation therapy conducted at the University of Oslo and Norway’s Radium Hospital. For more information, visit www.artbio.com, and follow us on LinkedIn and Twitter

As an emerging, global biotech with locations in Boston, Massachusetts, Basel, Switzerland, London, England and Oslo, Norway, we take advantage of diverse scientific depth and insights which makes ARTBIO a unique place to work.  We are driven by a desire to do better for cancer patients, lowering the burden of toleration and safety while at the same time raising the bar on clinical efficacy and duration. 

EEO Statement
ARTBIO is proud to be an equal opportunity workplace and is an affirmative action employer. We are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status. If you have a disability or special need that requires accommodation, please let us know.